Alder Matthias has filed 20 insider transactions across 1 company since March 2023.
Most recent transaction: a option exercise of 18750 shares of Gain Therapeutics, Inc. ($GANX) on March 26, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2024 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Common Stock | 18750 | $0.00 | 25,763.0000 | 13,011,361 | 267.36% | 0.14% |
| March 26, 2024 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Common Stock | 825 | $0.00 | 26,588.0000 | 13,011,361 | 3.20% | 0.01% |
| March 26, 2024 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Common Stock | 637 | $0.00 | 27,225.0000 | 13,011,361 | 2.40% | 0.00% |
| March 26, 2024 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | F | Common Stock | 6085 | $4.06 | 21,140.0000 | 13,011,361 | 22.35% | 0.05% |
| March 26, 2024 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Restricted Stock Units | 18750 | $0.00 | 56,250.0000 | 13,011,361 | 25.00% | 0.14% |
| March 26, 2024 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Restricted Stock Units | 825 | $0.00 | 8,250.0000 | 13,011,361 | 9.09% | 0.01% |
| March 26, 2024 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Restricted Stock Units | 637 | $0.00 | 6,376.0000 | 13,011,361 | 9.08% | 0.00% |
| March 21, 2024 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | A | Employee Stock Option (right to buy) | 370000 | $0.00 | 370,000.0000 | 13,011,361 | 9999.99% | 2.84% |
| Dec. 20, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Common Stock | 637 | $0.00 | 5,492.0000 | 12,701,401 | 13.12% | 0.01% |
| Dec. 21, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | S | Common Stock | 206 | $2.46 | 5,286.0000 | 12,701,401 | 3.75% | 0.00% |
| Dec. 20, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Restricted Stock Units | 637 | $0.00 | 7,013.0000 | 12,701,401 | 8.33% | 0.01% |
| Dec. 7, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | S | Common Stock | 1820 | $2.50 | 4,855.0000 | 12,701,401 | 27.27% | 0.01% |
| Oct. 1, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Common Stock | 825 | $0.00 | 6,675.0000 | 12,701,401 | 14.10% | 0.01% |
| Oct. 1, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Restricted Stock Units | 825 | $0.00 | 9,075.0000 | 12,701,401 | 8.33% | 0.01% |
| Sept. 20, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Common Stock | 2550 | $0.00 | 5,850.0000 | 12,387,089 | 77.27% | 0.02% |
| Sept. 20, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Restricted Stock Units | 2550 | $0.00 | 7,650.0000 | 12,387,089 | 25.00% | 0.02% |
| July 1, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Common Stock | 3300 | $0.00 | 3,300.0000 | 12,387,089 | 9999.99% | 0.03% |
| July 1, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | M | Restricted Stock Units | 3300 | $0.00 | 9,900.0000 | 12,387,089 | 25.00% | 0.03% |
| March 23, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 11,883,368 | 9999.99% | 1.26% |
| March 23, 2023 | Gain Therapeutics, Inc. | $GANX | Alder Matthias | Chief Executive Officer | A | Restricted Stock Units | 75000 | $0.00 | 75,000.0000 | 11,883,368 | 9999.99% | 0.63% |